Skip to content

Horizons Chronic Graft-Versus-Host-Disease Study

Multidisciplinary Intervention for Adults With Chronic Graft Versus Host Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06160986
Enrollment
20
Registered
2023-12-07
Start date
2023-12-27
Completion date
2026-09-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coping Skills, Graft Vs Host Disease, Quality of Life, Stem Cell Transplant Complications

Brief summary

This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

Interventions

BEHAVIORALHorizons Group Intervention

The Horizons Group intervention in English or Spanish language (per participant preference) contains 8 weekly group sessions delivered via video conference by a bone marrow transplant clinician and behavioral health specialist, over approximately 8 weeks, approximately 1.5 hours per session every week. The intervention pairs state-of-the-science information about survivorship and chronic graft versus host disease with self-management strategies. Intervention sessions will be delivered via video conference (Zoom), which participants may access by computer, laptop, tablet, or smart phone. As part of the intervention, participants will have access to an intervention manual and audio-recorded relaxation exercises to support learning and skills practice.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* underwent allogeneic hematopoietic stem cell transplant * have moderate to severe chronic graft versus host disease * currently receiving care at the Sylvester Comprehensive Cancer Center Bone Marrow Transplant Program * able to participate in a group intervention in English or Spanish language

Exclusion criteria

* comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention * vulnerable patients, defined here as prisoners and pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Percentage of participant enrollmentBaseline (pre-intervention) to 10-week follow-upParticipant enrollment will be demonstrated if ≥50% eligible participants enroll
Percentage of participant attendanceBaseline (pre-intervention) to 10-week follow-upParticipant attendance will be demonstrated if ≥80% participants complete ≥4 of 8 sessions
Percentage of participant retentionBaseline (pre-intervention) to 10-week follow-upParticipant retention will be demonstrated if ≥80% participants are retained in the study at week 10.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLara Traeger, PhD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026